Stay updated with breaking news from 21835210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.18 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Corcept Therapeutics (NASDAQ:CORT – […]
HC Wainwright reissued their buy rating on shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $38.00 price target on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Truist Financial lifted their price target on […]
Hussman Strategic Advisors Inc. cut its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 16.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,500 shares of the biotechnology company’s stock after selling 10,500 shares during the period. Hussman Strategic Advisors […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Joseph Douglas Lyon sold 5,443 shares of the firm’s stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $26.00, for a total transaction of $141,518.00. Following the completion of the transaction, the insider now directly owns 7,314 shares […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Joseph Douglas Lyon sold 5,443 shares of the stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $26.00, for a total value of $141,518.00. Following the completion of the transaction, the insider now directly owns 7,314 […]